Cerebellum and Cortical Plasticity: the Case of Dystonia
CERDYS
2 other identifiers
interventional
120
1 country
1
Brief Summary
Purpose \- Objective : Sensorimotor adaptation allows the modification of the motor command taking into account the errors detected during execution of prior movements. It involves a large cortico-subcortical network. Isolated lesions of this network do not systematically alter sensorimotor adaptation except for cerebellar lesions. The cerebellum is thus a key structure for sensorimotor adaptation. However, the link between cerebellar and the cortical plasticity underlying sensorimotor adaptation remain unknown. Alteration of sensorimotor adaptation is associated with dystonia but it is unclear whether it is a cause or consequence of dystonia. It has been hypothesized that the abnormal plasticity observed in dystonia could account for the associated alteration of sensorimotor adaptation. Classically, basal ganglia dysfunction is considered to be crucial for dystonia pathogenesis. However, recent studies suggest that the involvement of the cerebellum may also be important in this setting. In primary dystonia, imaging studies showed abnormal cerebellar activation during sensorimotor adaptation tasks and neurophysiological studies demonstrated a decrease of cerebellar output. The aim of this study is to investigate the role of the cerebellum in the cortical plasticity underlying sensorimotor adaptation both in healthy subjects (normal plasticity) and in dystonic patients (abnormal plasticity). \- Methods: Paired associative stimulation PAS consists in repetitive pairing of a peripheral nerve and a cortical stimulation. This kind of stimulation has been designed to induce artificial plasticity that can be easily measured. This PAS induced sensorimotor plasticity is exacerbated and has lost its topographical specificity in dystonic patients.TMS using trains of TMS pulses (rTMS) can be applied on the cerebellum to modulate its output. We will test the effect of rTMS induced modulation (cTBS- inhibitory, iTBS-excitatory, sham) of the cerebellar output on PAS induced plasticity in patients with dystonia and healthy control. We will also assess the acute effect of the rTMS induced modulation of the cerebellar output on the dystonic symptoms and on the performance at a validated sensorimotor adaptation task. This will be done by double blind post-hoc scoring of the dystonia (BFM or TWSTRS) on standardized videorecording and measurement of the performance at the task after each rTMS session (cTBS, iTBS, sham). Finally, we will assess the variation of PAS effect on other parameters reflecting cortical excitability after each rTMS session (cTBS, iTBS, sham).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 5, 2011
CompletedFirst Posted
Study publicly available on registry
January 7, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 24, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 24, 2012
CompletedSeptember 4, 2025
January 1, 2025
1.8 years
January 5, 2011
August 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of MEP0/MEP10 and MEP0/MEP30 values obtained after sham, cRTBS or iTBS of the cerebellum.
The effect of rTMS induced modulation of the cerebellar output on the PAS induced plasticity will be assessed by measurement of the size variation of a 1mV test motor evoked potential (which reflect cortical excitability) before (MEP0) and 10 and 30 minutes (MEP10 and MEP30) after PAS. The primary outcome measure will be the comparison of MEP0/MEP10 and MEP0/MEP30 values obtained after sham, cRTBS or iTBS of the cerebellum.
6 weeks
Secondary Outcomes (3)
Variation of the appropriate dystonic clinical score (depending on the type of dystonia) after each rTMS session (cTBS, iTBS, sham).
6 weeks
Measurement of number of errors, mean time to reach the target after each rTMS session (cTBS, iTBS, sham).
6 weeks
Measurement of the variation of the motor threshold, intracortical inhibition and intracortical facilitation after each rTMS session (cTBS, iTBS, sham).
6 weeks
Study Arms (4)
Primary cervical dystonia Patients
EXPERIMENTALPrimary upperlimb Dystonia Patients
EXPERIMENTALSecondary Cervical or Upperlimb Dystonia due to cerebral palsy
EXPERIMENTALHealthy volunteers
OTHERInterventions
Transcranial magnetic stimulation (PAS and rTMS)
Eligibility Criteria
You may qualify if:
- All subjects
- Age \>18 years and \< 70 years
- Normal physical and neurological examination, except for dystonia (when present)
- No treatment with botulinum toxin during the last three months
- No treatment altering the cortical excitability
- Agreement to use a medically acceptable method of contraception throughout the study for female of childbearing potential
- Primary focal dystonia group
- Patients with cervical and/or upper limb dystonia
- No cause of secondary dystonia
- Secondary dystonia group
- Cervical dystonia and/or upper limb dystonia History of perinatal anoxia
You may not qualify if:
- MMS ≤ 24/30
- Current neurological or psychiatric illness other than dystonia.
- Individual who is on medication which is known to lower seizure threshold (see lists above), or who has a pacemaker, an implanted medical pump, a metal plate, a metal plate or metal object in the skull or eye (for example after brain surgery) will be excluded
- Uncontrollable medical problems not related to dystonia such as; cardiopulmonary disease, severe rheumatoid arthritis, active joint deformity of arthritic origin, active cancer, or renal disease
- Previous history of seizure(s) or current active epilepsy
- Pregnancy, breast feeding women and women who are of childbearing age and not practicing adequate birth control.
- Patients legally protected
- Patients who are not enrolled at social security
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hpôpital Pitié Sapétrière - U 975 Plate forme " Pole Exploration de l'homme : Gait, Equilibrium, Posture, and Movement "
Paris, 75013, France
Related Publications (1)
Hubsch C, Roze E, Popa T, Russo M, Balachandran A, Pradeep S, Mueller F, Brochard V, Quartarone A, Degos B, Vidailhet M, Kishore A, Meunier S. Defective cerebellar control of cortical plasticity in writer's cramp. Brain. 2013 Jul;136(Pt 7):2050-62. doi: 10.1093/brain/awt147.
PMID: 23801734BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Emmanuel Roze, MD, PhD
Institut National de la Santé Et de la Recherche Médicale, France
- PRINCIPAL INVESTIGATOR
Asha Kishore, MD
Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST)
- PRINCIPAL INVESTIGATOR
Margherita Russo, MD
Policlinico G . Martino
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 5, 2011
First Posted
January 7, 2011
Study Start
January 1, 2011
Primary Completion
October 24, 2012
Study Completion
October 24, 2012
Last Updated
September 4, 2025
Record last verified: 2025-01